Literature DB >> 10554999

Pseudolymphomatous folliculitis: a clinicopathologic study of 15 cases of cutaneous pseudolymphoma with follicular invasion.

E Arai1, H Okubo, T Tsuchida, K Kitamura, I Katayama.   

Abstract

We report the clinical, histopathologic, and immunohistologic features of 15 cases of pseudolymphomatous folliculitis (PLF). The patients comprised seven males and eight females (mean age, 38.6 years; age range, 2-67 years). All patients had dome-shaped or flat-elevated nodules suggestive of cutaneous lymphoid hyperplasias (CLHs). The lesions were solitary in all 15 cases, except in one case with duplex lesions. All lesions were located on the face and measured less than 1.5 cm. In 14 cases with one lesion each, five lesions showed rapid regression after incisional biopsy, whereas the remaining nine underwent excisional biopsy. In the case with duplex lesions, one regressed spontaneously after excisional biopsy of the other. Histopathologically, all PLFs showed dense lymphocytic infiltrates from the dermis to the subcutis simulating cutaneous lymphomas. The walls of hair follicles in all cases were enlarged and irregularly deformed with their epithelium blurred by lymphocytic infiltrates; we called this change "activation" of hair follicles. In nine cases, many atypical lymphocytes were intermingled; three of these cases had been misdiagnosed as cutaneous T-cell lymphoma at other institutions. Immunohistologically, 10 and 5 cases showed predominantly B cells and predominantly T cells, respectively. Remarkably, all lesions showed increased numbers of perifollicular histiocytes expressing anti-S-100 protein and CD1a, and seven lesions showed histiocytes in aggregates. We conclude that PLF is a subset of CLH with characteristic clinical and pathologic features showing perifollicular clustering of T-cell-associated dendritic cells with activation of pilosebaceous units. PLF is an entity to be differentiated from malignant lymphomas and other cutaneous pseudolymphomas.

Entities:  

Mesh:

Year:  1999        PMID: 10554999     DOI: 10.1097/00000478-199911000-00001

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  9 in total

1.  Inflammatory features of frontal fibrosing alopecia.

Authors:  Sophia A Ma; Sotonye Imadojemu; Kenneth Beer; John T Seykora
Journal:  J Cutan Pathol       Date:  2017-06-01       Impact factor: 1.587

2.  Follicular mycosis fungoides - A report of four Indian cases.

Authors:  T Rajalakshmi; Y K Inchara; Meryl Antony
Journal:  Indian J Med Paediatr Oncol       Date:  2009-07

3.  Pseudolymphomatous folliculitis: a distinctive cutaneous lymphoid hyperplasia.

Authors:  Rameshwar M Gutte
Journal:  Indian J Dermatol       Date:  2013-07       Impact factor: 1.494

4.  Pseudolymphomatous folliculitis on the nose.

Authors:  Aya Kakizaki; Taku Fujimura; Ikuko Numata; Akira Hashimoto; Setsuya Aiba
Journal:  Case Rep Dermatol       Date:  2012-01-30

5.  Dermoscopy findings of pseudolymphomatous folliculitis.

Authors:  Taku Fujimura; Takanori Hidaka; Akira Hashimoto; Setsuya Aiba
Journal:  Case Rep Dermatol       Date:  2012-07-12

6.  Multiple nodules on the left cheek represented pseudolymphomatous folliculitis.

Authors:  Masaru Horikiri; Naho Abe; Kazuki Ueda
Journal:  Clin Case Rep       Date:  2016-05-04

Review 7.  Dermatological Considerations in the Diagnosis and Treatment of Marginal Zone Lymphomas.

Authors:  Andrea Ronchi; Antonello Sica; Paola Vitiello; Renato Franco
Journal:  Clin Cosmet Investig Dermatol       Date:  2021-03-08

8.  CD1a expression by Barrett's metaplasia of gastric type may help to predict its evolution towards cancer.

Authors:  F Cappello; F Rappa; R Anzalone; G La Rocca; G Zummo
Journal:  Br J Cancer       Date:  2005-03-14       Impact factor: 7.640

Review 9.  Approach to Cutaneous Lymphoid Infiltrates: When to Consider Lymphoma?

Authors:  Yann Vincent Charli-Joseph; Michelle Gatica-Torres; Laura Beth Pincus
Journal:  Indian J Dermatol       Date:  2016 Jul-Aug       Impact factor: 1.494

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.